as on March 5, 2026 at 9:31 pm IST
Day's Low
Day's High
2.51%
Downside
0.47%
Upside
52 Week's Low
52 Week's High
21.77%
Downside
2.66%
Upside
as on March 5, 2026 at 4:01 pm IST
Market Cap
₹36,434.98 Cr
Return on Equity (ROE)
26.05
PE Ratio (TTM)
35.92
Return on capital employed (ROCE)
32.78
Industry PE ratio
42.01
Beta (LTM)
0.65
P/B Ratio
9.05
Dividend Yield
1.07
PEG Ratio
3.71
Quarterly Earnings Growth YOY
17.56
EPS (TTM)
73.43
Sector
Pharmaceuticals
Book Value
302.38
Technical Analysis
Bullish
View Technical Analysis
as on March 5, 2026 at 4:01 pm IST
Ajanta Pharma in the last 5 years
Lowest (17.12x)
June 6, 2018
Today (35.92x)
March 4, 2026
Industry (42.01x)
March 4, 2026
Highest (50.52x)
September 10, 2024
Today’s Price to Earnings Ratio: 35.92x
Compare market cap, revenue, PE, and other key metrics of Ajanta Pharma with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| BUY | 36,434.98 | 29.92% | 0.52 | 920 | 4,648 | |
| BUY | 8,808.51 | -10.7% | 0.52 | 413 | 2,013 | |
| BUY | 69,429.03 | 7.71% | 0.60 | 3,483 | 31,723 | |
| HOLD | 90,249.13 | 20.56% | 0.61 | 4,614 | 23,241 | |
| BUY | 59,128.13 | 17.72% | 0.00 | 1,414 | 6,445 |
Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data
92.86%
Buy
0.00%
Hold
7.14%
Sell
Search interest for Ajanta Pharma Ltd Stock has decreased by -11% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Ajanta Pharma.
Ajanta Pharma Ltd’s net profit jumped 17.56% since last year same period to ₹273.77Cr in the Q3 2025-2026. On a quarterly growth basis, Ajanta Pharma Ltd has generated 5.22% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending September 2025, Ajanta Pharma Ltd has declared dividend of ₹28.00 per share on 03 Nov 2025 - translating a dividend yield of 0.96%.
Read More about DividendsCheck stock indices that include Ajanta Pharma.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
![]()
Netprofit is up for the last 4 quarters, 225.26 Cr → 273.77 Cr (in ₹), with an average increase of 6.2% per quarter
Price Rise
![]()
In the last 1 month, AJANTPHARM stock has moved up by 3.5%
MF Holding Up
![]()
Mutual Funds have increased holdings from 14.67% to 15.49% in Dec 2025 quarter
Promoter Holding Unchanged
![]()
Promoters holdings remained unchanged at 66.25% of holdings in Dec 2025 quarter
Against Peers
![]()
In the last 1 year, Torrent Pharmaceuticals Ltd has given 45.7% return, outperforming this stock by 31.9%
Against Peers
![]()
In the last 3 years, Torrent Pharmaceuticals Ltd has given 188.9% return, outperforming this stock by 39.5%
Retail Holding Down
![]()
Retail Investor have decreased holdings from 7.32% to 7.19% in Dec 2025 quarter
Revenue Fall
![]()
Revenue is down for the last 2 quarters, 1.41K Cr → 1.39K Cr (in ₹), with an average decrease of 0.9% per quarter
FII Holding Down
![]()
Foreign Institutions have decreased holdings from 8.53% to 7.98% in Dec 2025 quarter
| Organisation | Ajanta Pharma Ltd |
| Industry | Pharmaceuticals |
| CEO | Mannalal B Agrawal |
| E-voting on shares | Click here to vote |
Ajanta Pharma share price today stands at ₹2974.9 as on at the close of the market. Ajanta Pharma share today touched a day high of ₹2988.9 and a low of ₹2900.1.
Ajanta Pharma touched a 52 week high of ₹3054 and a 52 week low of ₹2327.3. Ajanta Pharma share price today i.e. is closed at ₹2974.9, which is -2.59% down from its 52 week high and 27.83% up from its 52 week low.
Ajanta Pharma market capitalisation is ₹36,434.98 Cr as on .
To buy Ajanta Pharma shares, you need to follow these steps:
Ajanta Pharma trading volume is 1.11L as on . This means that 1.11L shares of Ajanta Pharma were bought and sold on the stock market during today's trading session.